The impact of one fraction of 8 Gy radiotherapy in palliative treatment of multiple myeloma patients with painful bone destructions

被引:4
作者
Rudzianskiene, Milda [1 ]
Inciura, Arturas [1 ]
Juozaityte, Elona [1 ]
Gerbutavicius, Rolandas [1 ]
Simoliuniene, Renata [2 ]
Rudzianskas, Viktoras [1 ]
Kiavialaitis, Greta Emilia [3 ]
机构
[1] Lithuanian Univ Hlth Sci, Inst Oncol, Kaunas, Lithuania
[2] Lithuanian Univ Hlth Sci, Dept Phys Math & Biophys, Kaunas, Lithuania
[3] Univ Hosp Aachen, Dept Anesthesiol, Aachen, Germany
关键词
Multiple myeloma; pain relief; radiotherapy; recalcification; QUALITY-OF-LIFE; SPINAL-CORD COMPRESSION; RADIATION-THERAPY; EUROPEAN-ORGANIZATION; RANDOMIZED-TRIAL; SINGLE FRACTION; MULTIFRACTION RADIOTHERAPY; CLINICAL-TRIALS; METASTASES; CANCER;
D O I
10.3906/sag-1403-103
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/aim: Radiotherapy is required to overcome pain and to promote recalcification in multiple myeloma (MM) patients. The aim of our prospective study was to evaluate the impact of one fraction of 8 Gy regimen in palliative treatment of MM. Materials and methods: Forty-six patients with MM and painful bone destructions were treated by 8 Gy single fraction regimen. The visual analog scale was used for evaluation of pain. Analgesic use was measured prior to and after radiotherapy (4, 12, and 24 weeks). Recalcification was evaluated with radiographs before and after radiotherapy at 1 and 3 months. Quality of life questionnaires were completed before and 4 weeks after treatment. Results: Decrease of pain was observed in 78.3% cases: according to the international consensus on palliative radiotherapy criteria, 43.5% were found to be completely and 34.8% partially responsive. Reduction of analgesic use was present in 68.4% and complete cessation in 31.6%. Recalcification was present in 55%: a complete response was observed in 35% and a partial response in 20%. The side effects after treatment were of the first grade and reversible. Conclusion: One fraction of 8 Gy regimen is effective palliative treatment of MM patients with painful bone destructions.
引用
收藏
页码:364 / 371
页数:8
相关论文
共 50 条
  • [41] Single versus multiple fractions of palliative radiotherapy for bone metastases: a randomized clinical trial in Iranian patients
    Amouzegar-Hashemi, F.
    Behrouzi, H.
    Kazemian, A.
    Zarpak, B.
    Haddad, P.
    CURRENT ONCOLOGY, 2008, 15 (03) : 36 - 39
  • [42] Focused Ultrasound and RadioTHERapy for non-invasive palliative pain treatment in patients with bone metastasis: a study protocol for the three armed randomized controlled FURTHER trial
    Slotman, Derk J.
    Bartels, Marcia M. T. J.
    Ferrer, Cyril J.
    Bos, Clemens
    Bartels, Lambertus W.
    Boomsma, Martijn F.
    Phernambucq, Erik C. J.
    Nijholt, Ingrid M.
    Morganti, Alessio G.
    Siepe, Giambattista
    Buwenge, Milly
    Gruell, Holger
    Bratke, Grischa
    Yeo, Sin Yuin
    Blanco Sequeiros, Roberto
    Minn, Heikki
    Huhtala, Mira
    Napoli, Alessandro
    De Felice, Francesca
    Catalano, Carlo
    Bazzocchi, Alberto
    Gasperini, Chiara
    Campanacci, Laura
    Galendi, Julia Simoes Correa
    Mueller, Dirk
    Braat, Manon N. G. J. A.
    Moonen, Chrit
    Verkooijen, Helena M.
    TRIALS, 2022, 23 (01)
  • [43] Comparison of Single versus Multiple Fractions for Palliative Treatment of Painful Bone Metastasis: Firs Study from North West India
    Kapoor, Akhil
    Singhal, Mukesh Kumar
    Bagri, Puneet Kumar
    Nirban, Raj Kumar
    Maharia, Sitaram
    Narayan, Satya
    Kumar, Harvindra Singh
    INDIAN JOURNAL OF PALLIATIVE CARE, 2015, 21 (01) : 45 - 48
  • [44] Influence of the treatment schedule on the physicians' decisions to refer bone metastases patients for palliative radiotherapy: a questionnaire survey of physicians in various specialties
    Saito, Tetsuo
    Toya, Ryo
    Semba, Akiko
    Matsuyama, Tomohiko
    Oya, Natsuo
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2016, 78 (03): : 275 - 284
  • [45] Viewpoint on the impact of interferon in the treatment of multiple myeloma:: benefit for a small proportion of patients?
    Bladé, J
    Esteve, J
    MEDICAL ONCOLOGY, 2000, 17 (02) : 77 - 84
  • [46] Impact of Extended Treatment Interval on the Prognosis of Multiple Myeloma Patients: A Retrospective Study
    Sun, Chao
    Ye, Jian-Nan
    Mao, Jing-Jue
    Ma, Ke-Wa
    Zhou, Xin
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (11) : 592 - 604
  • [47] Economic Analysis of Radiation Therapy Oncology Group 97-14 Multiple Versus Single Fraction Radiation Treatment of Patients With Bone Metastases
    Konski, Andre
    James, Jennifer
    Hartsell, William
    Leibenhaut, Mark H.
    Janjan, Nora
    Curran, Walter
    Roach, Mack
    Watkins-Bruner, Deborah
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (04): : 423 - 428
  • [48] Viewpoint on the impact of interferon in the treatment of multiple myeloma: benefit for a small proportion of patients?
    J Bladé
    J Esteve
    Medical Oncology, 2000, 17 : 77 - 84
  • [49] Prognostic Factors Influencing Survival and a Treatment Pattern Analysis of Conventional Palliative Radiotherapy for Patients with Bone Metastases
    Ignat, Patricia
    Todor, Nicolae
    Ignat, Radu-Mihai
    Suteu, Ofelia
    CURRENT ONCOLOGY, 2021, 28 (05) : 3876 - 3890
  • [50] Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment
    Du, WL
    Hattori, Y
    Hashiguchi, A
    Kondoh, K
    Hozumi, N
    Ikeda, Y
    Sakamoto, M
    Hata, J
    Yamada, T
    PATHOLOGY INTERNATIONAL, 2004, 54 (05) : 285 - 294